103 related articles for article (PubMed ID: 8760297)
1. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.
Martin DC; Rüther U; Sanchez-Sweatman OH; Orr FW; Khokha R
Oncogene; 1996 Aug; 13(3):569-76. PubMed ID: 8760297
[TBL] [Abstract][Full Text] [Related]
2. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.
Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R
Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210
[TBL] [Abstract][Full Text] [Related]
3. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance.
Buschow C; Charo J; Anders K; Loddenkemper C; Jukica A; Alsamah W; Perez C; Willimsky G; Blankenstein T
J Immunol; 2010 Mar; 184(6):2930-8. PubMed ID: 20142365
[TBL] [Abstract][Full Text] [Related]
6. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
7. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
8. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
9. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
[TBL] [Abstract][Full Text] [Related]
10. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE
EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.
Tran PL; Vigneron JP; Pericat D; Dubois S; Cazals D; Hervy M; DeClerck YA; Degott C; Auclair C
Cancer Gene Ther; 2003 Jun; 10(6):435-44. PubMed ID: 12768188
[TBL] [Abstract][Full Text] [Related]
12. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V
Oncogene; 1998 Sep; 17(10):1253-9. PubMed ID: 9771968
[TBL] [Abstract][Full Text] [Related]
14. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice.
de Coupade C; Gillet R; Bennoun M; Briand P; Russo-Marie F; Solito E
Hepatology; 2000 Feb; 31(2):371-80. PubMed ID: 10655260
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H
Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
17. Inducible formation of liver tumors in transgenic mice.
Rüther U; Woodroofe C; Fattori E; Ciliberto G
Oncogene; 1993 Jan; 8(1):87-93. PubMed ID: 8423999
[TBL] [Abstract][Full Text] [Related]
18. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
Robinson C; van Bruggen I; Segal A; Dunham M; Sherwood A; Koentgen F; Robinson BW; Lake RA
Cancer Res; 2006 Nov; 66(22):10786-94. PubMed ID: 17108115
[TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
